Regulus, Biogen Idec Partner on MS Biomarkers Genetic Engineering News BG-12 (dimethyl fumarate) is a small molecule immune modulator currently undergoing regulatory review. A PEGylated interferon beta-1a is currently in Phase III development for relapsing forms of MS, and a humanized IL2-receptor antibody, daclizumab, ... |
